Plasticity of neuroendocrine-thymus interactions during ontogeny and ageing: Role of zinc

NeuroImmune Biology

Volumn 4, Issue C, 2004, Pages 307-329

  Mocchegiani, Eugenio ^a   Giacconi, Robertina ^a   Muti, Elisa ^a   Muzzioli, Mario ^a   Cipriano, Catia ^a  

^a INRCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957097155     PISSN: 15677443     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-7443(04)80021-8     Document Type: Chapter

References (106)

1. Fabris N., Mocchegiani E., and Provinciali M. Plasticity of neuroendocrine-thymus interactions during aging. Exp Gerontol 32 (1997) 415-429
2. Savino W., and Dardenne M. Neuroendocrine control of thymus physiology. Endocr Rev 21 (2000) 412-413
3. Madden K.S., and Felten D.L. Experimental basis for neural-immune interactions. Physiol Rev 75 (1995) 77-106
4. Geenen V., Kecha O., Brilot F., Charlet-Renard C., and Martens H. The thymic repertoire of neuroendocrine-related self antigens: biological role in T-cell selection and pharmacological implications. Neuroimmunomodulation 6 (1999) 115-125
5. Fabris N., and Mocchegiani E. Endocrine control of thymic serum factor production in young-adult and old mice. Cell Immunol 91 (1985) 325-335
6. Besedovsky H.O., and del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev 17 (1996) 64-102
7. McCann S.M., Milenkovic L., Gonzales M.C., Lyson K., Karanth S., and Rettori V. Endocrine aspects of neuroimmunomodulation: Methods and Overview. In: De Souza E.B. (Ed). Neurobiology of Cytokines-A Volume of Methods in Neurosciences (1993), Academic Press, Boca Raton 187-201
8. Weigent D.A., and Blalock J.E. Association between the neuroendocrine and immune systems. Leukoc. Biol. 58 (1995) 137-150
9. Mocchegiani E., Giacconi R., Cipriano C., Muzzioli M., Gasparini N., Moresi R., Stecconi R., Suzuki H., Cavalieri E., and Mariani E. MtmRNA gene expression, via IL-6 and glucocorticoids, as potential genetic marker of immunosenescence: lessons from very old mice and humans. Exp Gerontol 37 (2002) 349-357
10. Savino W., Arzt E., and Dardenne M. Immunoneuroendocrine connectivity: the paradigm of the thymus-hypothalamus/pituitary axis. Neuroimmunomodulation 6 (1999) 126-136
11. Mocchegiani E., Muzzioli M., Cipriano C., and Giacconi R. Zinc, T-cell pathways, aging: role of metallothioneins. Mech Ageing Dev 106 (1998) 183-204
12. Mocchegiani E., Muzzioli M., and Giacconi R. Zinc and immunoresistance to infection in aging: new biological tools. Trends Pharmacol Sci 21 (2000) 205-208
13. Anderson G., and Jenkinson E.J. Lymphostromal interactions in thymic development and function. Nat Rev Immunol 1 (2001) 31-40
14. Res P., and Spits H. Developmental stages in the human thymus. Semin Immunol 11 (1999) 39-46
15. Ritter M.A., and Palmer D.B. The human thymic microenvironment: new approaches to functional analysis. Semin Immunol 11 (1999) 13-21
16. Alves L.A., de Carvalho A.C., and Savino W. Gap junctions: a novel route for direct cell-cell communication in the immune system. Immunol Today 19 (1998) 269-275
17. Patel D.D., and Haynes B.F. Cell adhesion molecules involved in intrathymic T cell development. Semin Immunol 5 (1993) 282-292
18. Dunn A.J. Cytokine activation of the HPA axis. Ann N Y Acad Sci 917 (2000) 608-617
19. Hadden J.W. Thymic endocrinology. Ann N Y Acad Sci 840 (1998) 352-358
20. Champion S., Imhof B.A., Savagner P., and Thiery J.P. The embryonic thymus produces chemotactic peptides involved in the homing of hemopoietic precursors. Cell 44 (1986) 781-790
21. Moll J., Eibel H., Schmid P., Sansig G., Botteri F., Palacios R., and Van der Putten H. Thymic hyperplasia in transgenic mice caused by immortal epithelial cells expressing c-kit ligand. Eur J Immunol 22 (1992) 1587-1594
22. Muegge K., Vila M.P., and Durum S.K. Interleukin-7: a cofactor for V(D)J rearrangement of the T cell receptor beta gene. Science 261 (1993) 93-95
23. Rich B.E., and Leder P. Transgenic expression of interleukin 7 restores T cell populations in nude mice. J Exp Med 181 (1995) 1223-1228
24. Haks M.C., Oosterwegel M.A., Blom B., Spits H.M., and Kruisbeek A.M. Cell-fate decisions in early T cell development: regulation by cytokine receptors and the pre-TCR. Semin Immunol 11 (1999) 23-27
25. Kim C.H., and Broxmeyer H.E. Chemokines: signal lamps for trafficking of T and B cells for development and effector function. J Leukoc Biol 65 (1999) 6-15
26. Klug D.B., Carter C., Gimenez-Conti I.B., and Richie E.R. Cutting edge: thymocyte-independent and thymocyte-dependent phases of epithelial patterning in the fetal thymus. J Immunol 169 (2002) 2842-2845
27. Uehara A., Gillis S., and Arimura A. Effects of interleukin-1 on hormone release from normal rat pituitary cells in primary culture. Neuroendocrinology 45 (1987) 343-347
28. Bernton E.W., Beach J.E., Holaday J.W., Smallridge R.C., and Fein H.G. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science 238 4826 (1987 Oct 23) 519-521
29. Arzt E., Buric R., Stelzer G., Stalla J., Renner U., and Stalla G.K. Interleukin involvement in anterior pituitary cell growth regulation: effects of IL-2 and IL-6. Endocrinology 132 (1993) 459-467
30. Fukata J., Usui T., Naitoh Y., Nakai Y., and Imura H. Effects of recombinant human interleukin-1 alpha,-1 beta, 2 and 6 on ACTH synthesis and release in the mouse pituitary tumour cell line AtT-20. J Endocrinol 122 (1989) 33-39
31. Bateman A., Singh A., Kral T., and Solomon S. The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev 10 (1989) 92-112
32. Gaillard R.C., Turnill D., Sappino P., and Muller A.F. Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors. Endocrinology 127 (1990) 101-106
33. Lissoni P. The pineal gland as a central regulator of cytokine network. Neuroendocrinol Lett 20 (1999) 343-349
34. Denicoff K.D., Durkin T.M., Lotze M.T., Quinlan P.E., Davis C.L., Listwak S.J., Rosenberg S.A., and Rubinow D.R. The neuroendocrine effects of interleukin-2 treatment. J Clin Endocrinol Metab 69 (1989) 402-410
35. Spinedi E., and Gaillard R.C. Stimulation of the hypothalamo-pituitary-adrenocortical axis by the central serotonergic pathway: involvement of endogenous corticotropin-releasing hormone but not vasopressin. J Endocrinol Invest 14 (1991) 551-557
36. Karanth S., and McCann S.M. Anterior pituitary hormone control by interleukin 2. Proc Natl Acad Sci 88 (1991) 2961-2965
37. Smith L.R., Brown S.L., and Blalock J.E. Interleukin-2 induction of ACTH secretion: presence of an interleukin-2 receptor alpha-chain-like molecule on pituitary cells. J Neuroimmunol 21 (1989) 249-254
38. Vankelecom H., Matthys P., and Denef C. Involvement of nitric oxide in the interferon-gammainduced inhibition of growth hormone and prolactin secretion in anterior pituitary cell cultures. Mol Cell Endocrinol 129 (1997) 157-167
39. Withyachumnarnkul B., Nonaka K.O., Santana C., Attia A.M., and Reiter R.J. Interferon-gamma modulates melatonin production in rat pineal glands in organ culture. J Interf Res 10 (1990) 403-411
40. Dardenne M., Pleau J.M., Nabama B., Lefancier P., Denien M., Choay J., and Bach J.F. Contribution of zinc and other metals to the biological activity of the serum thymic factors. Proc Natl Acad Sci USA 79 (1982) 5370-5375
41. Migliorati G., Nicoletti F., D'Adamio F., Spreca A., Pagliacci C., and Riccardi C. Dexamethasone induces apoptosis in mouse natural killer cells and cytotoxic T. lymphocytes. Immunology 81 (1994) 21-26
42. Iwata M., Hanaoka S., and Sato K. Rescue of thymocytes and T-cell hybridomas from glucocorticoidsinduced apoptosis by stimulation via the T cell receptors/CD3 complex: A possible in vitro model for posstive selection of the T cell repertoire. Eur J Immunol 21 (1991) 643-649
43. Sei Y., Yoshimoto K., Mcintyre A., Skolnick P., and Arora P.K. Morphine-induced thymic hypoplasia is glucocorticoid dependent. J Immunol 146 (1991) 194-198
44. Goya R.G., Sosa Y.E., Console G.M., and Dardenne M. Altered thyrotropic and somatotropic responses to environmental challenges in congenitally athymic mice. Brain Behav Immun 9 (1995) 79-86
45. Daneva T., Spinedi E., Hadid R., and Gaillard R.C. Impaired hypothalamo-pituitary-adrenal axis function in Swiss nude athymic mice. Neuroendocrinology 62 (1995) 79-86
46. Goya R.G., Brown O.A., and Bolognani F. The thymus-pituitary axis and its changes during aging. Neuroimmunomodulation 6 (1999) 137-142
47. Hadley A.J., Rantle C.M., and Buckingham J.C. Thymulin stimulates corticotrophin release and cyclic nucleotide formation in the rat anterior pituitary gland. Neuroimmunomodulation 4 (1997) 62-69
48. Angioni S., Iori G., Cellini M., Sardelli S., Massolo F., Petraglia F., and Genazzani A.R. Acute beta-interferon or thymopentin administration increases plasma growth hormone and cortisol levels in children. Acta Endocrinol (Copenh) 127 (1992) 237-241
49. Malaise M.G., Hazee-Hagelstein M.T., Reuter A.M., Vrinds-Gevaert Y., Goldstein G., and Franchimont P. Thymopoietin and thymopentin enhance the levels of ACTH, beta-endorphin and beta-lipotropin from rat pituitary cells in vitro. Acta Endocrinol (Copenh) 115 4 (1987 Aug) 455-460
50. Goya R.G., Sosa Y.E., Brown O.A., and Dardenne M. In vitro studies on the thymus-pituitary axis in young and old rats. Ann N Y Acad Sci 741 (1994) 108-114
51. Tijerina M., Gorospe W.C., Bowman K.L., Badamchian M., Goldstein A.L., and Spangelo B.L. A novel thymosin peptide stimulates interleukin-6 release from rat C6 glioma cells in vitro. Neuroimmunomodulation 4 (1997) 163-170
52. Milenkovic L., Lyson K., Aguila M.C., and McCann S.M. Effect of thymosin alpha 1 on hypothalamic hormone release. Neuroendocrinology 56 (1992) 674-679
53. Prasad A.S. Clinical, endocrinological and biochemical effects of zinc deficiency. Clin Endocrinol Metab 14 3 (1985 Aug) 567-589
54. Prasad A.S., Fitzgerald J.T., Hess J.W., Kaplan J., Pelen F., and Dardenne M. Zinc deficiency in elderly patients. Nutrition 9 (1993) 218-224
55. Fabris N., and Mocchegiani E. Zinc, human diseases and aging. Review article. Aging Clin Exp Res 7 (1995) 77-93
56. Shankar A.H., and Prasad A.S. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr 68 (1998) 447S-463S
57. Fabris N., Mocchegiani E., Amadio L., Zannotti M., Licastro F., and Franceschi C. Thymic hormone deficiency in normal aging and Down's syndrome: Is there a primary failure of the thymus?. Lancet 1 (1984) 983-986
58. Garvy B.A., Telford W.G., King L.E., and Fraker P.J. Glucocorticoids and irradiation-induced apoptosis in normal murine bone marrow B-lineage lymphocytes as determined by flow cytometry. Immunology 79 (1993) 270-277
59. Mocchegiani E., and Muzzioli M. Therapeutic application of zinc in human immunodeficiency virus against opportunistic infections. J Nutr 130 (2000) 1424S-1431S
60. McCabe Jr. M.J., Aijiang S., and Orrenius S. Chelation of intracellular zinc triggers apoptosis in mature thymocytes. Lab. Invest. 69 (1993) 101-110
61. Fraker P.J., and Telford W.G. A reappraisal of the role of zinc in life and death decisions of cells. Proc Soc Exp Biol Med 215 (1997) 229-236
62. MacLean K.H., Cleveland J.L., and Porter J.B. Cellular zinc content is a major determinant of iron chelator-induced apoptosis of thymocytes. Blood 98 (2001) 3831-3839
63. Barbieri D., Troiano L., Grassilli E., Agnesini C., Cristofalo E.A., Monti D., Capri M., Cossarizza A., and Franceschi C. Inhibition of apoptosis by zinc: a reappraisal. Biochem Biophys Res Commun 187 (1992) 1256-1261
64. Lanningham-Foster L., Green C.L., Langkamp-Henken B., Davis B.A., Nguyen K.T., Bender, and Cousins R.J. Overexpression of CRIP in transgenic mice alters cytokine patterns and the immune response. Am J Physiol Endocrinol Metab 282 (2002) E1197-E1203
65. Aspinall R., and Andrew D. Thymic involution in aging. J Clin Immunol 20 (2000) 250-256
66. Mocchegiani E., Santarelli L., Muzzioli M., and Fabris N. Reversibility of the thymic involution and of age-related immune dysfunctions by zinc supplementation in old mice. Int J Immunopharmacol 17 (1995) 703-718
67. Mocchegiani E., and Fabris N. Age-related thymus involution zinc reverses in vitro the thymulin secretion defect. Int J Immunopharmacol 17 (1995) 745-749
68. Mocchegiani E., Builian D., Santarelli L., Tibaldi A., Muzzioli M., Pierpaoli W., and Fabris N. The immuno-reconstituting effect of melatonin of pineal grafting and its relation to zinc pool in aging mice. J Neuroimmunol 53 (1994) 189-201
69. Pierpaoli W., and Regelson W. Pineal control of aging: Effect of melatonin and pineal grafting on aging mice. Proc Natl Acad Sci USA 91 (1994) 787-791
70. Mocchegiani E., Santarelli L., Tibaldi A., Muzzioli M., Bulian D., Cipriano K., Olivieri F., and Fabris N. Presence of links between zinc and melatonin during the circadian cycle in old mice: effects on thymic endocrine activity and on the survival. J Neuroimmunol 86 (1998) 111-122
71. Kelley K.W., Brief S., Westly H.J., Novakofsky J., Bechitel P.J., Simon J., and Walker E.B. GH3 pituitary adenoma cells can reverse thymic aging in rats. Proc Natl Acad Sci USA 83 (1986) 5663-5667
72. Davila D.R., Brief S., Simon J., Hammer R.E., Brinster R.L., and Kelly K.W. Role of growth hormone in regulating T-dependent immune events in aged, nude and transgenic rodents. J Neurosci Res 18 (1987) 108-116
73. Goff B.L., Roth J.A., Arp L.H., and Incefy G.S. Growth hormone treatment stimulates thymulin production in aged dogs. Clin Exp Immunol 65 (1987) 580-587
74. Binz K., Joller P., Froesch P., Binz H., Zapf J., and Froesch E.R. Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor I. Proc Natl Acad Sci USA 87 (1990) 3690-3694
75. Greenstein B.D., Fitzpatrick F.T., Kendall M.D., and Wheeler M.J. Regeneration of the thymus in old male rats treated with a stable analogue of LHRH. J Endocrinol 112 (1987) 345-350
76. Marchetti B., Morale M.C., Batticane N., Gallo F., Farinelli Z., and Cioni M. Aging of the reproductive-neuroimmune axis. Ann NY Acad Sci 621 (1991) 159-173
77. Fabris N., Muzzioli M., and Mocchegiani E. Recovery of age-dependent immunological deterioration in Balb/c mice by short-term treatment with L-thyroxine. Mech Ageing Dev 18 (1982) 327-338
78. Fabris N., Mocchegiani E., Muzzioli M., and Piloni S. Recovery of age related decline of thymic endocrine activity and PHA response by lysine-arginine combination. Int J Jmmunopharmacol 8 (1986) 677-685
79. Dardenne M., Bukaiba N., Gagnerault M.C., Homo-Delarche F., Chappuis P., Lemmonnier D., and Savino W. Restoration of the thymus in aging mice by in vivo zinc supplementation. Clin Immunol Immunopathol 66 (1993) 127-135
80. Fabris N., and Mocchegiani E. Immunomodulating role of growth hormone. In: Bercu B.B., and Walker R.F. (Eds). Growth Hormone II (1994), Springer Verlag, New York 116-130
81. Fabris N., and Mocchegiani E. Arginine-containing compounds and thymic endocrine activity. Thymus 19 (1992) S21-S30
82. Mocchegiani E., Giacconi R., Cipriano C., Gasparini N., Orlando F., Stecconi R., Muzzioli M., Isani G., and Carpenè E. Metallothioneins (I+II) and thyroid-thymus axis efficiency in old mice: role of corticosterone and zinc supply. Mech Ageing Dev 123 (2002) 675-694
83. Simpson J.C., Gray E.S., Michie W., and Beck J.S. The influence of preoperative drug treatment on the extent of hyperplasia of the thymus in primary thyrotoxicosis. Clin Exp Immunol 22 (1975) 249-253
84. Fabris N., Mocchegiani E., Mariotti S., Pacini F., and Pinchera A. Thyroid function modulates thymus endocrine activity. J. Clin Endocrinol Metab 62 (1986) 474-478
85. Boukaiba N., Flament C., Acher S., Chappuis P., Piau A., Fusselier M., Dardenne M., and Lemonnier D. A physiological amount of zinc supplementation: effects on nutritional, lipid, and thymic status in an elderly population. Am J Clin Nutr 57 (1993) 566-572
86. Bogden J.D., Oleske J.M., Lavenhar M.A., Munves E.M., Kemp F.W., Bruening K.S., Holding K.J., Denny T.N., Guarino M.A., and Holland B.K. Effects of one year of supplementation with zinc and other micronutrients on cellular immunity in the elderly. J Am Coll Nutr 9 (1990) 214-225
87. Mocchegiani E., Muzzioli M., Gaetti R., Veccia S., Viticchi C., and Scalise G. Contribution of zinc to reduce CD4+ risk factor for 'severe' infection relapse in aging: parallelism with HIV. Int J Immunopharmacol 21 (1999) 271-281
88. Fabris N., Pierpaoli W., and Sorkin E. Hormones and the immunological capacity. 3. The immunodeficiency disease of the hypopituitary Snell-Bagg dwarf mouse. Clin Exp Immunol 9 (1971) 209-225
89. Roth J.A., Laeberle M.L., Grier D.L., Hopper J.G., Spiegel H.E., and Macallister H.A. Improvement in clinical condition and thymic morphological features associated with growth treatment of immuno-deficient dwarf-dogs. Am J Vet Res 45 (1984) 1151-1155
90. Wise T., MacDonald G.J., Klindt J., and Ford J.J. Characterization of thymic weight and thymic peptide thymosin-beta 4: effects of hypophysectomy, sex, and neonatal sexual differentiation. Thymus 19 (1992) 235-244
91. Mocchegiani E., Sartorio A., Santarelli L., Ferrero S., and Fabris N. Thymulin, zinc and insulin-like growth factor-I (IGF-I) activity before and during recombinant growth hormone (rec-GH) therapy in children and adults with GH deficiency. J Endocrinol Invest 19 (1996) 630-637
92. Muller E.E., Rigamonti A.E., Colonna Vde G., Locatelli V., Berti F., and Cella S.G. GH-related and extra-endocrine actions of GH secretagogues in aging. Neurobiol Aging 23 (2002) 907-919
93. Hirokawa K., Utsuyama M., Kasai M., Konno A., Kurashima C., and Moriizumi E. Age-related hyperplasia of the thymus and T-cell system in the Buffalo rat. Immunological and immunohistological studies. Virchows Arch B Cell Pathol Incl Mol Pathol 59 (1990) 38-47
94. Mocchegiani E., Cacciatore L., Talarico M., Lingetti M., and Fabris N. Recovery of low thymic hormone levels in cancer patients by lysine-arginine combination. Int J Immunopharmacol 12 (1990) 365-371
95. Ban E., Gagnerault M.C., Jammes H., Postel-Vinay M.C., Haour F., and Dardenne M. Specific binding sites for growth hormone in cultured mouse thymic epithelial cells. Life Sci 48 (1991) 2141-2148
96. Mocchegiani E., Paolucci P., Balsamo A., Cacciari E., and Fabris N. Influence of growth hormone on thymic endocrine activity in humans. Horm Res 33 (1990) 248-255
97. Timsit J., Savino W., Safieh B., Chanson P., Gagnerault M.C., Bach J.F., and Dardenne M. Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. J Clin Endocrinol Metab 75 (1992) 183-188
98. Dardenne M., Kelly P.A., Bach J.F., and Savino W. Identification and function activity of prolactin receptors in thymic epithelial cells. Proc Natl Acad Sci USA 88 (1991) 9700-9704
99. Cunningham B.C., Bass S., Fuh G., and Wells J.A. Zinc mediation of the binding of human growth hormone to the human prolactin receptor. Science 250 (1990) 1709-1712
100. MacDonald R.S. The role of zinc in growth and cell proliferation. J Nutr 130 (2000) 1500S-1508S
101. Maestroni G.J. The immunoneuroendocrine role of melatonin. J Pineal Res 14 (1993) 1-10
102. Sainz R.M., Mayo J.C., Uria H., Kotler M., Antolin I., Rodriguez C., and Menendez-Pelaez A. The pineal neurohormone melatonin prevents in vivo and in vitro apoptosis in thymocytes. J Pineal Res 19 (1995) 178-188
103. Provinciali M., Di Stefano G., Bulian D., Tibaldi A., and Fabris N. Effect of melatonin and pineal grafiing on thymocyte apoptosis in aging mice. Mech Ageing Develop 90 (1996) 1-19
104. Martin-Cacao A., Lopez-Gonzales M.A., Calvo J.R., Seguraand J.J., and Guerrero J.M. Melatonin binding sites in rat thymus during development. In: Touitou Y., Arendt J., and Pevet P. (Eds). Melatonin and the Pineal Gland (1993), Elsevier, Amsterdam 379-382
105. Reiter R.J., Tan D.X., Poeggeler B., Chen L.D., and Menendez-Pelaez A. Melatonin, free radicals and cancer initiation. In: Maestroni G.J.M., Conti A., and Reiter R. (Eds). Advances in Pineal Research (1994), John Libbey, London 211-228
106. Pieri C., Marra M., Moroni F., Recchioni R., and Marcheselli F. Melatonin: A peroxil radical scavenger more effective than vitamin E. Life Sci 55 (1994) 271-276